1. Home
  2. ESPR vs CIX Comparison

ESPR vs CIX Comparison

Compare ESPR & CIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • CIX
  • Stock Information
  • Founded
  • ESPR 2008
  • CIX 1993
  • Country
  • ESPR United States
  • CIX United States
  • Employees
  • ESPR N/A
  • CIX N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • CIX Industrial Machinery/Components
  • Sector
  • ESPR Health Care
  • CIX Consumer Discretionary
  • Exchange
  • ESPR Nasdaq
  • CIX Nasdaq
  • Market Cap
  • ESPR 305.0M
  • CIX 258.7M
  • IPO Year
  • ESPR 2013
  • CIX 1998
  • Fundamental
  • Price
  • ESPR $0.95
  • CIX $25.90
  • Analyst Decision
  • ESPR Buy
  • CIX
  • Analyst Count
  • ESPR 7
  • CIX 0
  • Target Price
  • ESPR $6.07
  • CIX N/A
  • AVG Volume (30 Days)
  • ESPR 5.5M
  • CIX 8.6K
  • Earning Date
  • ESPR 05-06-2025
  • CIX 05-06-2025
  • Dividend Yield
  • ESPR N/A
  • CIX 4.80%
  • EPS Growth
  • ESPR N/A
  • CIX N/A
  • EPS
  • ESPR N/A
  • CIX 1.35
  • Revenue
  • ESPR $332,314,000.00
  • CIX $145,941,000.00
  • Revenue This Year
  • ESPR $5.17
  • CIX N/A
  • Revenue Next Year
  • ESPR N/A
  • CIX N/A
  • P/E Ratio
  • ESPR N/A
  • CIX $19.23
  • Revenue Growth
  • ESPR 185.66
  • CIX N/A
  • 52 Week Low
  • ESPR $0.93
  • CIX $17.89
  • 52 Week High
  • ESPR $3.94
  • CIX $36.10
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 22.73
  • CIX 65.25
  • Support Level
  • ESPR $0.93
  • CIX $19.21
  • Resistance Level
  • ESPR $1.06
  • CIX $22.09
  • Average True Range (ATR)
  • ESPR 0.09
  • CIX 1.75
  • MACD
  • ESPR -0.02
  • CIX 0.61
  • Stochastic Oscillator
  • ESPR 3.57
  • CIX 100.00

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.

Share on Social Networks: